J&J Beats Estimates, Raises Outlook as Demand for Medtech Products Grows

Key things Johnson & Johnson’s second-quarter profit and revenue beat estimates. The company benefited from seniors undergoing procedures delayed by COVID-19 and higher demand for its medical products. JNJ raised its full-year revenue and sales forecast. Johnson & Johnson stock (JNJ) advanced as the pharmaceutical and health products company reported better-than-expected results and raised its […]